Red (2) Scare

Carper, Jean
November 1975
New Republic;11/8/75, Vol. 173 Issue 19, p5
The article focuses on concerns regarding the clean chit given to a food dye called Red number 2 by the U.S. Food and Drug Administration (FDA) for the last 15 years, despite indications that it has harmful effects. According to a report issued by the U.S. General Accounting Office, the FDA's 15-year delay over Red 2 exposes the public to unnecessary risk. The report urged the FDA to either declare Red 2 safe or ban it from food, drugs and cosmetics.


Related Articles

  • THE NEW REPUBLIC'S BEST BOOKS.  // New Republic;8/13/84, Vol. 191 Issue 7/8, p42 

    Lists the books reviewed and recommended by the magazine. "Karl Marx Collective: Economy, Society and Religion in a Siberian Collective Farm," by Caroline Humphrey; "A Very Private Eye: An Autobiography in Diaries and Letters," by Barbara Pym; "Infante's Inferno," by G. Cabrera; "Motives for...

  • Rules and Regulations: DEPARTMENT OF HEALTH AND HUMAN SERVICES.  // Federal Register (National Archives & Records Service, Office of;3/7/2013, Vol. 78 Issue 45, p14664 

    The article offers information on the technical amendments by the U.S. Food and Drug Administration (FDA) on its regulations on food and color additives. The technical amendments include the corrections of misspelled chemical names in § 73.3129, 176.180, and 177.1210, table entry in §...

  • Artificial Coloring and Hyperactivity. Park, Alice // Time International (Asia Edition);4/11/2011, Vol. 177 Issue 14, p14 

    The article reports on the move by a U.S. Food and Drug Administration committee to review previous studies which suggest that artificial food colorings can worsen hyperactivity symptoms in children who are already vulnerable to behavioral problems related to hyperactivity.

  • GMA Defends Artificial Food Colors.  // Supermarket News Exclusive Insight;3/31/2011, p8 

    The article reports on the defense made by the Grocery Manufacturers Association (GMA) before the U.S. Food & Drug Administration's Food Advisory Committee Meeting on March 31, 2011 concerning the safety of artificial food colors.

  • News Briefs.  // Dermatology Times;May2005, Vol. 26 Issue 5, p20 

    The article presents news briefs related to public health from the U.S. The advisory panel decision of the U.S. Food and Drug Administration to recommend the sale of silicone gel breast implants has outraged the American Academy of Cosmetic Surgery. A polyphenol derived from the extract of green...

  • Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies. Nguyen, Diane; Seoane-Vazquez, Enrique; Rodriguez-Monguio, Rosa; Montagne, Michael // BMC Health Services Research;2013, Vol. 13 Issue 1, p1 

    Background: The United States (US) Food and Drug Administration (FDA) is responsible for the protection of the public health by assuring the safety, effectiveness and security of human drugs and biological products through the enforcement of the Federal Food, Drug and Cosmetic Act (FDCA) and...

  • FDA, states collaborate for safety's sake. Henkel, John // FDA Consumer;Mar1996, Vol. 30 Issue 2, p27 

    Discusses the collaboration between the Food and Drug Administration (FDA) and states to protect the public's health and safety. Inspection of mammography facilities; Enforcement of compliance for the commodities covered under cooperative programs; Public Health Service (PHS) Act; Radiological...

  • Strategic Priorities Outlined by FDA.  // Chain Drug Review;5/23/2011, Vol. 33 Issue 9, p72 

    The article reports on the release the Food and Drug Administration's (FDA) final version of a strategic priorities document titled "Strategic Priorities 2011-2015: Responding to the Public Health Challenges of the 21st Century" in the U.S.

  • FDA gives recommendations for unapproved drug, medical device uses. Haigh, Christen // Infectious Diseases in Children;Mar2009, Vol. 22 Issue 3, p27 

    The article offers information on the recommendations released by the U.S. Food and Drug Administration (FDA) for the distribution of publications on unapproved uses of approved drugs and cleared medical devices


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics